The estimated Net Worth of Glenn Sblendorio is at least $13.2 Million dollars as of 7 March 2024. Mr. Sblendorio owns over 15,000 units of IVERIC bio Inc stock worth over $3,339,660 and over the last 19 years he sold ISEE stock worth over $7,362,713. In addition, he makes $2,462,150 as President, Chief Executive Officer, and Director at IVERIC bio Inc.
Sign up
Mr. Sblendorio ISEE stock SEC Form 4 insiders trading
Glenn has made over 66 trades of the IVERIC bio Inc stock since 2007, according to the Form 4 filled with the SEC. Most recently he exercised 15,000 units of ISEE stock worth $42,000 on 7 March 2024.
The largest trade he's ever made was exercising 125,000 units of IVERIC bio Inc stock on 16 January 2013 worth over $2,495,000. On average, Glenn trades about 9,217 units every 46 days since 2006. As of 7 March 2024 he still owns at least 83,596 units of IVERIC bio Inc stock.
You can see the complete history of Mr. Sblendorio stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Glenn Sblendorio biography
Glenn P. Sblendorio serves as President, Chief Executive Officer, Director of the Company. He assumed the position of chief executive officer in July 2017, in addition to his role as president, and has served as a member of our board of directors since May 2017. Mr. Sblendorio has served as our president since January 2017 and previously served as our executive vice president and chief operating officer from April 2016 to January 2017. In addition, he served as our chief financial officer and treasurer from April 2016 until April 2017. Mr. Sblendorio previously served as a member of our board of directors from July 2013 through March 2016. Prior to joining us, Mr. Sblendorio served as the president and chief financial officer of The Medicines Company, a publicly traded medical solutions company, from March 2006 until December 2015. Mr. Sblendorio served as executive vice president and chief financial officer of Eyetech Pharmaceuticals, Inc. from February 2002 until it was acquired by OSI Pharmaceuticals, Inc. in November 2005. From July 2000 to February 2002, Mr. Sblendorio served as senior vice president of business development at The Medicines Company. Mr. Sblendorio currently serves as a member of the board of directors of Amicus Therapeutics Inc. and Intercept Pharmaceuticals, Inc., both of which are publicly traded biopharmaceutical companies, and previously served on the board of directors of The Medicines Company. Mr. Sblendorio received a B.B.A. from Pace University and an M.B.A. from Fairleigh Dickinson University.
What is the salary of Glenn Sblendorio?
As the President, Chief Executive Officer, and Director of IVERIC bio Inc, the total compensation of Glenn Sblendorio at IVERIC bio Inc is $2,462,150. There are no executives at IVERIC bio Inc getting paid more.
How old is Glenn Sblendorio?
Glenn Sblendorio is 64, he's been the President, Chief Executive Officer, and Director of IVERIC bio Inc since 2017. There are 3 older and 11 younger executives at IVERIC bio Inc. The oldest executive at IVERIC bio Inc is Calvin Roberts, 67, who is the Independent Director.
What's Glenn Sblendorio's mailing address?
Glenn's mailing address filed with the SEC is 47 HULFISH STREET, , PRINCETON, NJ, 08542.
Insiders trading at IVERIC bio Inc
Over the last 5 years, insiders at IVERIC bio Inc have traded over $8,677,595 worth of IVERIC bio Inc stock and bought 130,569 units worth $624,325 . The most active insiders traders include Glenn Sblendorio, Venture Capital Iv, L.P.Ver..., and Keith Westby. On average, IVERIC bio Inc executives and independent directors trade stock every 15 days with the average trade being worth of $848,338. The most recent stock trade was executed by Keith Westby on 3 July 2023, trading 20,000 units of ISEE stock currently worth $58,800.
What does IVERIC bio Inc do?
we are a biopharmaceutical company specializing in the development of novel therapeutics to treat diseases of the back of the eye, with a focus on developing therapeutics for age-related macular degeneration (amd).
What does IVERIC bio Inc's logo look like?
Complete history of Mr. Sblendorio stock trades at Amicus Therapeutics Inc, Intercept Pharmaceuticals Inc, and IVERIC bio Inc
IVERIC bio Inc executives and stock owners
IVERIC bio Inc executives and other stock owners filed with the SEC include:
-
Glenn Sblendorio,
President, Chief Executive Officer, Director -
David Guyer,
Executive Chairman of the Board -
Anthony S. Gibney,
Exec. VP and Chief Bus. & Strategy Officer -
David Carroll,
Chief Financial Officer, Senior Vice President, Treasurer -
Keith Westby,
Chief Operating Officer, Senior Vice President -
Glenn P. Sblendorio M.B.A.,
CEO & Director -
Dr. Pravin U. Dugel M.D.,
Pres -
David F. Carroll M.B.A.,
Sr. VP, CFO & Treasurer -
Christopher Paul Simms,
Sr. VP & Chief Commercial Officer -
David F. Carroll,
Sr. VP, CFO & Treasurer -
Keith Westby M.B.A.,
Sr. VP & COO -
Calvin Roberts,
Independent Director -
Jane Henderson,
Independent Director -
Adrienne Graves,
Lead Independent Director -
Axel Bolte,
Independent Director -
Kathy Galante,
Vice President, Investor Relations and Corporate Communications -
Mark Blumenkranz,
Director -
Abraham Scaria,
Chief Scientific Officer -
Evelyn Harrison,
Sr. VP & Chief Clinical Operations Officer -
Amy R. Sheehan,
Sr. VP & Chief HR Officer -
Todd D.C. Anderman,
Sr. VP, Gen. Counsel & Corp. Sec. -
Dr. Xiao-Ping Dai Ph.D.,
Chief Technical Officer -
Dr. Samir C. Patel,
Co-Founder and Consultant -
Christopher Paul Simms,
SVP, Chief Commercial Officer -
Christine Ann Miller,
Director -
David E Redlick,
Director -
Venture Capital Iv, L.P.Ver...,
-
Anthony S Gibney,
EVP, Chief Business Officer -
Pravin Dugel,
President